Elsevier

Psychoneuroendocrinology

Volume 75, January 2017, Pages 132-140
Psychoneuroendocrinology

Effects of mineralocorticoid-receptor stimulation on risk taking behavior in young healthy men and women

https://doi.org/10.1016/j.psyneuen.2016.10.018Get rights and content

Highlights

  • Administration of Fludrocortisone increased risk taking behavior.

  • This effect was observed in men and women.

  • We found higher risk taking in men compared to women.

Abstract

Risk taking is influenced by stress, with riskier decisions after exposure to an acute stressor and consecutively elevated cortisol levels. In the brain, cortisol acts on two receptors with different functional profiles: the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR).

In the current study we investigated the effect of MR stimulation on risk taking behavior in 80 young healthy participants (40 women, mean age = 23.9). We administered 0.4 mg fludrocortisone, a MR agonist, in a between-subjects, placebo controlled design. Subsequently, participants conducted an established risk taking paradigm, the Balloon-Analogue-Risk-Task (BART). We also used two questionnaires to assess risk taking and decision behavior as trait measures.

We found a treatment effect with riskier decisions in the fludrocortisone group. Furthermore, we found a sex effect with more risk taking in men. There was no statistically significant interaction between both factors.

Our results indicate that acute MR stimulation leads to riskier decisions in women and men. Our findings argue for an important role of the MR in decision making processes.

Introduction

Stress, conceptualized as a threat to the physiological and psychological integrity of the organism, requires specific cognitive and behavioral adjustments. Situational affordances demand quick action to counter the threat and cope with the stressor(McEwen, 1998). For instance, acute stress has been shown to induce a shift from deliberate, goal-directed behavior towards habitual and intuitive behavior (Schwabe and Wolf, 2011), a shift that is reflected in the activation of different information processing systems (Margittai et al., 2015). Risk taking behavior as a process affected by stress has only recently received research attention. In general, exposure to an acute stressful situation increases the tendency for risk taking (Morgado et al., 2015, Starcke and Brand, 2012). However, experimental results regarding stress effects on risk taking are equivocal and affected by personality characteristics such as impulsivity and sensation seeking (Lejuez et al., 2002, Wise et al., 2014). Some studies report divergent effects for men and women (Lighthall et al., 2009, Lighthall et al., 2012, van den Bos et al., 2009) or gains and losses (Buckert et al., 2014, Pabst et al., 2013b, Porcelli and Delgado, 2009), with other studies finding no effects of stress at all (Haushofer et al., 2013).

Comparatively little research has been devoted to the underlying neuroendocrine mechanisms of stress effects on risk taking behavior. Following the short-lived activation of the catecholaminergic stress system, the glucocorticoid cortisol is secreted from the adrenals and becomes centrally active by crossing the blood-brain barrier. These two stress systems are the main physiological mechanisms for behavioral effects of stress. In an early study, van Honk et al. (2003) reported an influence of basal cortisol levels on punishment sensitivity and reward dependency in a risk taking task, with more disadvantageous choices for participants with low cortisol levels. Another study (Chumbley et al., 2014) that investigated basal cortisol levels (derived from hair samples) found a positive relationship between endogenous cortisol levels and aversion for losses. Pabst et al. (2013a) reported decreased risk taking when the decision task was performed 5 or 18 min after a psychosocial stressor – but an increase in a 28 min delay. This result was explained by the authors with differential effects of rapidly-acting catecholamines and delayed effects of cortisol. In a direct pharmacological design, the administration of exogenous cortisol (hydrocortisone) increased risky decision making in male participants (Putman et al., 2010). These findings support the role of the cortisol system in the stress-induced modulation of risk taking.

Cortisol can easily cross the blood–brain barrier and feeds back on the brain via two different receptor types: the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR), with the MR occurring both in the cell nucleus and the membrane. Unlike the permanently occupied nuclear MR, the membrane-bound MR plays an active role in the acute stress response (Vogel et al., 2016). While cortisol effects on the brain have traditionally been attributed to the activation of the GR complex, recent studies could demonstrate the significance of the MR for various psychological domains (de Kloet, 2014, Groeneweg et al., 2011, Ter Horst et al., 2012), with both receptor types promoting differential, and to some degree opposing functional processes (Hermans et al., 2014, Vogel et al., 2016). Activation of the MR can improve executive functions and memory performance (Hinkelmann et al., 2014, Otte et al., 2015, Schultebraucks et al., 2016a), while blockade of the MR impaired these processes (Cornelisse et al., 2011, Otte et al., 2007, Rimmele et al., 2013). Furthermore, the MR seems to be specifically involved in emotional processing and the appraisal of novel situations; these are functions that rely on anatomical structures such as the amygdala and the prefrontal cortex, that also underlie reward processing, outcome prediction and risk assessment (Gathmann et al., 2014, Maier et al., 2015, Porcelli et al., 2012). Accordingly, the stress induced shift towards a cognitively less demanding amygdala-based learning strategy is mediated by MR activation (Vogel et al., 2015). Specific MR haplotypes are linked to dispositional optimism (Klok et al., 2011), which can be conceived as high expectations regarding future outcomes (Carver and Scheier, 2014). Recent studies in rats that investigated time-dependent effects of corticosterone (the cortisol equivalent in rodents) on reward-based decision-making imply differential effects for MR- and GR-mediated processes (Koot et al., 2013, Koot et al., 2014).

These receptor-specific effects cannot be differentially assessed by hydrocortisone administration because hydrocortisone acts on both MR and GR. In this study we examined the specific effects of MR stimulation on risk taking. To this end, we administered fludrocortisone, a selective MR agonist, to healthy young men and women in a placebo controlled, double-blind, full-factorial design. Risk taking was assessed with the Balloon Analogue Risk Task (BART), an established measure of risk taking behavior that has previously been applied to investigate stress effects on risk taking (Lighthall et al., 2009, Lighthall et al., 2012, Mehta et al., 2015; Reynolds et al., 2013). Since previous studies could demonstrate sex differences in risk taking behavior, we included sex as a factor in our analysis.

We hypothesized that participants in the fludrocortisone condition would show increased risk taking when compared to participants in the placebo condition. Based on the generally stronger risk tolerance in men (Byrnes et al., 1999), we expected men to exhibit riskier decision making compared to women. Since conflicting results have been reported regarding sex specific effects of stress on risk taking (Starcke and Brand, 2012), our study remains exploratory with regard to an interaction between sex and our drug intervention.

Section snippets

Participants

In total, 80 (40 women, age 18–30 years, mean age = 23.9 ± 3.3) healthy participants completed the study. Participants were undergraduate students, recruited at the Humboldt University and Free University Berlin. They received a monetary compensation of 40€.

The sex ratio was balanced for each condition. One male participant had to be excluded because of technical difficulties.

Exclusion criteria were any neurological, psychiatric or psychological disorders, acute or persistent medical disease and

Demographic data

Participants in the treatment conditions (fludrocortisone vs. placebo) did not differ with regard to age, sex, BMI, smoking or hormonal contraception (see Table 1).

Questionnaire data

There was no significant difference between treatment groups for any of the three dimensions of the MDBF, the DOSPERT or the DMI-45 (p > 0.05) (see Table 2).

Salivary cortisol responses

We found a significant treatment × time interaction (F 4,284 = 9.71, p <0.001; ηp2 = 0.12). Post-hoc t-tests revealed a significant difference between treatment groups for the measurement

Discussion

In the current study, we investigated the effect of MR-receptor stimulation by fludrocortisone on risk taking behavior. Consistent with our hypothesis, we found increased risk taking in the fludrocortisone group, as compared to placebo. This finding is in line with the large number of previous studies that have investigated stress effects or effects of exogenous cortisol on risk taking (Morgado et al., 2015, Starcke and Brand, 2012). Riskier decision making after administration of exogenous

Conflict of interest

Christian Otte has received honoraria fees for lectures from Lundbeck and Servier and has received compensation as a member of the scientific advisory board from Lundbeck. Christian Eric Deuter, Katja Wingenfeld, Katharina Schultebrauks, Julian Hellmann-Regen, Dominique Piber report no conflict of interest.

Funding

No external funding.

Disclosure

Christian Otte has received honoraria fees for lectures from Lundbeck and Servier and has received compensation as a member of the scientific advisory board from Lundbeck. Christian Eric Deuter, Katja Wingenfeld, Katharina Schultebrauks, Julian Hellmann-Regen, Dominique Piber report no conflict of interest.

Contributors

Christian Eric Deuter: Statistical analysis, literature research, wrote the manuscript.

Katharina Schultebrauks: Data collection, statistical analysis, data management, recruitment of participants.

Katja Wingenfeld: Co-PI, study design, supervising statistics, literature research, supervising the manuscript.

Dominique Piber: Data collection, statistical analysis, data management, recruitment of participants.

Julian Hellmann-Regen: Analysis and interpretation of cortisol data.

Christian Otte: PI,

Acknowledgement

We would like to thank all participants who took part in this study.

References (83)

  • S. Koot et al.

    Time-dependent effects of corticosterone on reward-based decision-making in a rodent model of the Iowa Gambling Task

    Neuropharmacology

    (2013)
  • C.W. Lejuez et al.

    Evaluation of the Balloon Analogue Risk Task (BART) as a predictor of adolescent real-world risk-taking behaviours

    J. Adolesc.

    (2003)
  • S.U. Maier et al.

    Acute stress impairs self-control in goal-directed choice by altering multiple functional connections within the brain's decision circuits

    Neuron

    (2015)
  • P.H. Mehta et al.

    Testosterone and cortisol jointly modulate risk-taking

    Psychoneuroendocrinology

    (2015)
  • C. Otte et al.

    The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone

    Life Sci.

    (2003)
  • S. Pabst et al.

    Stress and decision making: a few minutes make all the difference

    Behav. Brain Res.

    (2013)
  • X.R. Qi et al.

    Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients

    Psychoneuroendocrinology

    (2013)
  • H. Rao et al.

    Neural correlates of voluntary and involuntary risk taking in the human brain: an fMRI Study of the Balloon Analog Risk Task (BART)

    Neuroimage

    (2008)
  • E.K. Reynolds et al.

    Influence of social stress on risk-taking behavior in adolescents

    J. Anxiety Disord.

    (2013)
  • L. Schwabe et al.

    Stress-induced modulation of instrumental behavior: from goal-directed to habitual control of action

    Behav. Brain Res.

    (2011)
  • K. Starcke et al.

    Decision making under stress: a selective review

    Neurosci. Biobehav. Rev.

    (2012)
  • J.P. Ter Horst et al.

    Stress or no stress: mineralocorticoid receptors in the forebrain regulate behavioral adaptation

    Neurobiol. Learn. Mem.

    (2012)
  • R. van den Bos et al.

    Stress and decision-making in humans: performance is related to cortisol reactivity, albeit differently in men and women

    Psychoneuroendocrinology

    (2009)
  • S. Vogel et al.

    A stress-induced shift from trace to delay conditioning depends on the mineralocorticoid receptor

    Biol. Psychiatry

    (2015)
  • S. Vogel et al.

    Cognitive adaptation under stress: a case for the mineralocorticoid receptor

    Trends Cogn. Sci.

    (2016)
  • K. Wingenfeld et al.

    Effects of mineralocorticoid receptor stimulation via fludrocortisone on memory in women with borderline personality disorder

    Neurobiol. Learn. Mem.

    (2015)
  • A.J. Bishara et al.

    Similar processes despite divergent behavior in two commonly used measures of risky decision making

    J. Behav. Decis. Mak.

    (2009)
  • A.-R. Blais et al.

    A domain-specific risk-taking (DOSPERT) scale for adult populations

    Judgment Decis. Mak.

    (2006)
  • M. Brand et al.

    Decision-making impairments in patients with Parkinson's disease

    Behav. Neurol.

    (2004)
  • M. Brand et al.

    Decision-making deficits of korsakoff patients in a new gambling task with explicit rules: associations with executive functions

    Neuropsychology

    (2005)
  • M. Buckert et al.

    Acute stress affects risk taking but not ambiguity aversion

    Front. Neurosci.

    (2014)
  • M.T. Buelow et al.

    The assessment of risky decision making: a factor analysis of performance on the Iowa Gambling Task, Balloon Analogue Risk Task, and Columbia Card Task

    Psychol. Assess.

    (2015)
  • J.P. Byrnes et al.

    Gender differences in risk taking: a meta-analysis

    Psychol. Bull.

    (1999)
  • J.A. Campbell et al.

    Impaired decision making on the Balloon Analogue Risk Task as a result of long-term alcohol use

    J. Clin. Exp. Neuropsychol.

    (2013)
  • J.R. Chumbley et al.

    Endogenous cortisol predicts decreased loss aversion in young men

    Psychol. Sci.

    (2014)
  • L. Clark et al.

    Social and emotional decision-making following frontal lobe injury

    Neurocase

    (2004)
  • S. Cornelisse et al.

    A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory

    Neuropsychopharmacology

    (2011)
  • E.R. de Kloet

    From receptor balance to rational glucocorticoid therapy

    Endocrinology

    (2014)
  • A.C. Dean et al.

    Is all risk bad? Young adult cigarette smokers fail to take adaptive risk in a laboratory decision-making test

    Psychopharmacology (Berl.)

    (2011)
  • B. Derntl et al.

    The impact of sex hormone concentrations on decision-making in females and males

    Front. Neurosci.

    (2014)
  • H.C. Devlin et al.

    Feeling good and taking a chance? Associations of hypomania risk with cognitive and behavioral risk taking

    Cogn. Ther. Res.

    (2015)
  • Cited by (15)

    • Stress effects on memory retrieval of aversive and appetitive instrumental counterconditioning in men

      2022, Neurobiology of Learning and Memory
      Citation Excerpt :

      Taking the interactive effects of cortisol and dopamine into account, the STARS (Stress Triggers Additional Reward Salience) model (Mather and Lighthall, 2012) states that stress promotes reward-related and disrupts punishment-related behavior, leading to increased approach and impaired avoidance learning. Thus, according to the STARS model stress hormones should facilitate risky and disadvantageous decisions and this effect has been shown to be especially pronounced in men (Deuter et al., 2017). Consequently, increases in approach behavior in stressed men as evident in the current study might be related to dopamine-related increases in reward sensitivity at the cost of avoidance behavior (Frank and Claus, 2006; Starcke and Brand, 2016).

    • The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression – Lessons from primary aldosteronism

      2020, Journal of Psychiatric Research
      Citation Excerpt :

      One possible explanation for this variability may be that sex hormones and contraceptives have an influence on the ARR (Pizzolo et al., 2010). MR function appears to be influenced by gender (Deuter et al., 2017; Ter Horst et al., 2012). This might suggest a direct influence of sex hormones and their variability on the MR.

    • Sleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression

      2019, Journal of Psychiatric Research
      Citation Excerpt :

      Sex differences were also described in animal data by Ter Horst et al. (Ter Horst, Carobrez, van der Mark, de Kloet and Oitzl, 2012) who proposed the MR to be involved in female stress and anxiety related disorders by additional modification by female sex hormones. Support comes from Deuter et al., (2017) who report sex differences in decision making after stimulation of the MR (Deuter et al., 2017). These results support the relevance of gender specific studies and treatment strategies in depression and anxiety.

    View all citing articles on Scopus
    View full text